NBIX logo

Neurocrine Biosciences (NBIX) Gross Margin

Annual Gross Margin

97.90%
-0.54%-0.55%

31 December 2023

NBIX Gross Margin Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Gross Margin

98.71%
+0.27%+0.27%

30 September 2024

NBIX Quarterly Gross Margin Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NBIX Gross Margin Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-0.6%+1.0%
3 y3 years-1.1%+0.1%
5 y5 years-1.0%-0.3%

NBIX Gross Margin High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-1.1%at low-0.0%+1.3%
5 y5 years-1.2%at low-0.5%+1.3%
alltimeall time-14.9%at low-16.8%+1.3%

Neurocrine Biosciences Gross Margin History

DateAnnualQuarterly
Sept 2024
-
98.71%(+0.3%)
June 2024
-
98.44%(-0.1%)
Mar 2024
-
98.54%(+0.2%)
Dec 2023
97.90%(-0.5%)
98.35%(+0.6%)
Sept 2023
-
97.75%(+0.3%)
June 2023
-
97.46%(-0.5%)
Mar 2023
-
97.98%(-0.2%)
Dec 2022
98.44%(-0.3%)
98.13%(-0.3%)
Sept 2022
-
98.43%(-0.3%)
June 2022
-
98.73%(+0.2%)
Mar 2022
-
98.52%(-0.2%)
Dec 2021
98.74%(-0.3%)
98.69%(+0.1%)
Sept 2021
-
98.58%(-0.4%)
June 2021
-
98.93%(+0.2%)
Mar 2021
-
98.77%(-0.1%)
Dec 2020
99.03%(-0.0%)
98.83%(-0.1%)
Sept 2020
-
98.96%(-0.3%)
June 2020
-
99.21%(+0.1%)
Mar 2020
-
99.11%(+0.1%)
Dec 2019
99.06%(+0.2%)
98.98%(-0.0%)
Sept 2019
-
99.01%(-0.1%)
June 2019
-
99.13%(-0.1%)
Mar 2019
-
99.21%(+0.4%)
Dec 2018
98.91%
98.82%(-0.2%)
Sept 2018
-
98.98%(-0.1%)
DateAnnualQuarterly
June 2018
-
99.12%(+0.5%)
Mar 2018
-
98.66%(-0.5%)
Dec 2017
99.22%(-13.8%)
99.20%(-0.1%)
Sept 2017
-
99.29%(+0.3%)
June 2017
-
99.04%(-14.9%)
Dec 2000
115.07%(+2.3%)
116.36%(+5.2%)
Sept 2000
-
110.58%(-6.5%)
June 2000
-
118.22%(-0.4%)
Mar 2000
-
118.68%(+3.8%)
Dec 1999
112.50%(+1.7%)
114.29%(+4.3%)
Sept 1999
-
109.62%(-0.8%)
June 1999
-
110.50%(-5.3%)
Mar 1999
-
116.67%(+7.1%)
Dec 1998
110.63%(+5.4%)
108.89%(-0.8%)
Sept 1998
-
109.80%(-6.5%)
June 1998
-
117.39%(+7.0%)
Mar 1998
-
109.76%(+3.1%)
Dec 1997
104.98%(-0.2%)
106.45%(+1.5%)
Sept 1997
-
104.84%(-1.3%)
June 1997
-
106.25%(+3.9%)
Mar 1997
-
102.25%(-0.9%)
Dec 1996
105.21%
103.23%(-9.2%)
Sept 1996
-
113.64%(+9.6%)
June 1996
-
103.64%(-5.0%)
Mar 1996
-
109.09%

FAQ

  • What is Neurocrine Biosciences annual gross profit margin?
  • What is the all time high annual gross margin for Neurocrine Biosciences?
  • What is Neurocrine Biosciences annual gross margin year-on-year change?
  • What is Neurocrine Biosciences quarterly gross profit margin?
  • What is the all time high quarterly gross margin for Neurocrine Biosciences?
  • What is Neurocrine Biosciences quarterly gross margin year-on-year change?

What is Neurocrine Biosciences annual gross profit margin?

The current annual gross margin of NBIX is 97.90%

What is the all time high annual gross margin for Neurocrine Biosciences?

Neurocrine Biosciences all-time high annual gross profit margin is 115.07%

What is Neurocrine Biosciences annual gross margin year-on-year change?

Over the past year, NBIX annual gross profit margin has changed by -0.54% (-0.55%)

What is Neurocrine Biosciences quarterly gross profit margin?

The current quarterly gross margin of NBIX is 98.71%

What is the all time high quarterly gross margin for Neurocrine Biosciences?

Neurocrine Biosciences all-time high quarterly gross profit margin is 118.68%

What is Neurocrine Biosciences quarterly gross margin year-on-year change?

Over the past year, NBIX quarterly gross profit margin has changed by +0.96% (+0.98%)